These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2109002)

  • 1. Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man.
    Lammers JW; Kioumis I; McCusker M; Nichol GM; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1990 Apr; 85(4):763-9. PubMed ID: 2109002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
    Camussi G; Tetta C; Segoloni G; Chiara Deregibus M; Bussolino F
    Agents Actions; 1981 Dec; 11(6-7):550-3. PubMed ID: 7041569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man.
    Kioumis I; Lammers JW; Dent G; Chung KF; Barnes PJ
    Prostaglandins; 1988 Sep; 36(3):343-54. PubMed ID: 3237997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketotifen inhibits the cutaneous but not the airway responses to platelet-activating factor in man.
    Chung KF; Minette P; McCusker M; Barnes PJ
    J Allergy Clin Immunol; 1988 Jun; 81(6):1192-8. PubMed ID: 3288683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
    Bellofiore S; Ciancio N; Pennisi A; Coco G; Passanisi G; Ricciardolo FL; Novo S; Di Maria GU
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):288-92. PubMed ID: 8000412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
    O'Connor BJ; Uden S; Carty TJ; Eskra JD; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1994 Jul; 150(1):35-40. PubMed ID: 8025768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of platelet-activating factor induced bronchoconstriction by nedocromil sodium.
    Hayes JP; Chung KF; Barnes PJ
    Eur Respir J; 1992 Nov; 5(10):1193-6. PubMed ID: 1336735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit.
    Camussi G; Tetta C; Bussolino F
    Prostaglandins; 1983 Mar; 25(3):343-51. PubMed ID: 6346397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.
    Wardlaw AJ; Chung KF; Moqbel R; MacDonald AJ; Hartnell A; McCusker M; Collins JV; Barnes PJ; Kay AB
    Am Rev Respir Dis; 1990 Feb; 141(2):386-92. PubMed ID: 2405759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled PAF fails to induce airway hyperresponsiveness to methacholine in normal human subjects.
    Lai CK; Jenkins JR; Polosa R; Holgate ST
    J Appl Physiol (1985); 1990 Mar; 68(3):919-26. PubMed ID: 2187854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous infusion of prostacyclin (PGI2) in man.
    O'Grady J; Warrington S; Moti MJ; Bunting S; Flower R; Fowle AS; Higgs EA; Moncada S
    Prostaglandins; 1980 Feb; 19(2):319-32. PubMed ID: 6992228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects.
    Chung KF; Barnes PJ
    Thorax; 1989 Feb; 44(2):108-15. PubMed ID: 2648646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular and platelet effects of epoprostenol (prostacyclin, PGI2) are unaffected by beta-adrenoceptor blockade in man.
    Hassan S; Pickles H; Fish A; Burke C; Warrington S; O'Grady J
    Br J Clin Pharmacol; 1982 Sep; 14(3):369-77. PubMed ID: 6127095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of theophylline on airway responses to inhaled platelet-activating factor in man.
    Chung KF; Lammers JW; McCusker M; Roberts NM; Nichol GM; Barnes PJ
    Eur Respir J; 1989 Sep; 2(8):763-8. PubMed ID: 2680584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics.
    Louis R; Bury T; Corhay JL; Radermecker M
    Chest; 1993 Sep; 104(3):806-10. PubMed ID: 8365293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute bronchial and hematologic effects following inhalation of a single dose of PAF. Comparison between asthmatics and normal subjects.
    Louis R; Bury T; Corhay JL; Radermecker MF
    Chest; 1994 Oct; 106(4):1094-9. PubMed ID: 7924479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
    Tam FW; Clague J; Dixon CM; Stuttle AW; Henderson BL; Peters AM; Lavender JP; Ind PW
    Am Rev Respir Dis; 1992 Oct; 146(4):1003-8. PubMed ID: 1416388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF).
    Cox CP; Linden J; Said SI
    Peptides; 1984; 5(2):325-8. PubMed ID: 6206481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostacyclin (PGI2) on immune-complex-induced neutropenia.
    Camussi G; Bussolino F; Tetta C; Caligaris Cappio F; Coda R; Macchiorlatti E; Alberton M; Roffinello C; Segoloni G
    Immunology; 1983 Apr; 48(4):625-33. PubMed ID: 6339375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.